Home › Core › ISCC-IDs › 28CrYCRj6b6iX

View ISCC-ID

Core Data

28CrYCRj6b6iX
ISCC-ID - digital asset identifier
CCNHCfrKaViXt-CTWLR5UmRh2gJ-CDAppjb5xfh5R-CReUcvDuo6zP7
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

metabolites of prostaglandin synthases as potential biomarkers of lyme disease severity and symptom resolution

Ledger Reference

coblo
Source Ledger/Blockchain
396939
N-th ISCC Decleration on source ledger
4f22d561152bef712f41b944dc1419c98658fa0d5370d6aad8ba4baa2ad169af
Hash of block that includes the ISCC-DECLARATION
58c9c5bb950127a00165e3b62cc8b4c0ac879424c70d941f7ea7017bd5d88d20
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Alicia Caroline Jarosz", "@type": "Person"}, {"name": "Alaa Badawi", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://link.springer.com/content/pdf/10.1007%2Fs00011-018-1180-5.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature America, Inc", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1007/s00011-018-1180-5", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCNHCfrKaViXt-CTWLR5UmRh2gJ-CDAppjb5xfh5R-CReUcvDuo6zP7", "propertyID": "ISCC"}], "datePublished": "2018-08-18"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close